These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27886615)
1. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin. Faxén UL; Hage C; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH Int J Cardiol; 2017 Feb; 228():709-716. PubMed ID: 27886615 [TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458 [TBL] [Abstract][Full Text] [Related]
3. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192 [TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction. Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction. Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133 [TBL] [Abstract][Full Text] [Related]
6. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes. Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866 [TBL] [Abstract][Full Text] [Related]
7. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP; Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728 [TBL] [Abstract][Full Text] [Related]
8. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction. Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF. Kang SH; Park JJ; Choi DJ; Yoon CH; Oh IY; Kang SM; Yoo BS; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Oh BH; Heart; 2015 Dec; 101(23):1881-8. PubMed ID: 26319121 [TBL] [Abstract][Full Text] [Related]
12. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction. Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053 [TBL] [Abstract][Full Text] [Related]
13. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum. Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415 [TBL] [Abstract][Full Text] [Related]
15. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP; Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682 [TBL] [Abstract][Full Text] [Related]
16. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051 [TBL] [Abstract][Full Text] [Related]